|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the NANO 8-K filed Nov 27, 2007. Item 7.01—Regulation FD Disclosure. On November 27, 2007, Bruce C. Rhine, Chairman of the Board of Nanometrics Incorporated (the “Company”) will deliver an analyst presentation that includes the slides filed as Exhibit 99.1 to this report which are incorporated herein by reference. The information in this current report on Form 8-K and the exhibit attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) nor otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, regardless of any general incorporation language in such filing. This excerpt taken from the NANO 8-K filed Nov 28, 2006. Item 7.01 – Regulation FD Disclosure. Nanometrics Incorporated (the “Company”) will hold an analyst and investor meeting on Wednesday, November 29, 2006 at the Company’s headquarters in Milpitas, California. Presentations will be made by senior executives regarding Nanometrics’ markets, products, operations and finances. The meeting is expected to begin at approximately 8:45 a.m. PST and conclude by 1:00 p.m. PST. A live webcast of the event will be made available on the Company’s website under the “Investor” heading at www.nanometrics.com. The information in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any of the Registrant’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |||||||||||||||